Confluent director exercises 30,000 options, sells 30,000 shares

Confluent (CFLT) Form 4: On 10/29/2025, a director exercised 30,000 stock options at $2.24, converting Class B into Class A, and sold 30,000 Class A shares pursuant to a Rule 10b5-1 plan adopted on June 10, 2025.

Accepted by SEC EDGAR 10/31/2025 - 05:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Confluent (CFLT) Form 4: On 10/29/2025, a director exercised 30,000 stock options at $2.24, converting Class B into Class A, and sold 30,000 Class A shares pursuant to a Rule 10b5-1 plan adopted on June 10, 2025. The sale occurred at prices ranging from $23.19 to $24.01. Following these transactions, the director directly held 28,549 Class A shares and indirectly held 1,787 shares via a trust.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 5 txns

Insider Narkhede Neha

Role Director

Sold 30,000 shs ($710K)

Approx. gross sale proceeds $710K

Approx. exercise cost $67K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	30,000	$0.00	$0.00
Exercise	Class B Common Stock	30,000	$0.00	$0.00
Conversion	Class B Common Stock	30,000	$0.00	$0.00
Conversion	Class A Common Stock	30,000	$0.00	$0.00
Sale	Class A Common Stock	30,000	$23.65	$710K
Holding	Class A Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 580,602 contracts (Direct); Class B Common Stock — 1,083,729 contracts (Direct); Class A Common Stock — 28,549 shares (Direct); Class A Common Stock — 1,787 shares (Indirect, By Trust)

Footnotes (4)

1. F1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.
2. F2. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.
3. F3. The shares were sold at prices ranging from $23.19 to $24.01 The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. Fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CFLT report on this Form 4?

A director exercised 30,000 options at $2.24, converted Class B to Class A, and sold 30,000 Class A shares.

When did the CFLT insider transactions occur?

The transactions took place on 10/29/2025.

At what prices were the Confluent shares sold?

Shares were sold at prices ranging from $23.19 to $24.01.

Was the sale under a Rule 10b5-1 plan?

Yes. The sales were under a Rule 10b5-1 plan adopted June 10, 2025.

What are the director’s holdings after the transactions?

Directly 28,549 Class A shares and indirectly 1,787 shares held by a trust.

What were the option terms involved in the exercise?

Stock option to buy 30,000 shares at $2.24, fully vested, expiring on 10/21/2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Narkhede Neha

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/29/2025		C		30,000	A	(1)	58,549	D
Class A Common Stock	10/29/2025		S		30,000(2)	D	$23.65(3)	28,549	D
Class A Common Stock								1,787	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.24	10/29/2025		M			30,000	(4)	10/21/2028	Class B Common Stock	30,000	$0	580,602	D
Class B Common Stock	(1)	10/29/2025		M		30,000		(1)	(1)	Class A Common Stock	30,000	$0	1,113,729	D
Class B Common Stock	(1)	10/29/2025		C			30,000	(1)	(1)	Class A Common Stock	30,000	$0	1,083,729	D

Explanation of Responses:

1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.

2. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.

3. The shares were sold at prices ranging from $23.19 to $24.01 The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Fully vested.

	/s/ Weilyn Wood, Attorney-in-Fact	10/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.